State and Demographic Variation in Use of Depot Antipsychotics by Medicaid Beneficiaries with Schizophrenia
Publisher: Psychiatric Services, Vol. 65, No. 1
Jan 30, 2014
This study found the use of injectable antipsychotics varied substantially among state Medicaid programs. African Americans received a disproportionate share in many states.
Comparative Effectiveness Research and Treatment of Serious Mental Illnesses in Medicaid
You may also like...
A First Step to Helping California Workers Keep Their Jobs: Identifying Likely SSDI Entrants Using State Disability Claims